Ozan Pamir

Insider Reports History

Location
San Francisco, CA
Signature
/s/ Jeong James Lee, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Ozan Pamir:

Company Role Class Num Shares Value Price $ Report Date Ownership
Niagen Bioscience, Inc. Chief Financial Officer Common Stock 7,372 $50,204 $6.81 14 Nov 2025 Direct
Niagen Bioscience, Inc. Chief Financial Officer Common Stock 2,220 $15,210 $6.85 14 Nov 2025 The reported securities are held by the reporting person's spouse.
180 Life Sciences Corp. CFO Common Stock 8,983 $1,689 $0.1880 04 Sep 2023 Direct
Niagen Bioscience, Inc. Chief Financial Officer Employee Stock Options (right to buy) 62,131 19 Feb 2026 Direct
180 Life Sciences Corp. CFO Stock Option (Right to Buy) 15,000 04 Sep 2023 Direct

Insider Reports Filed by Ozan Pamir

Symbol Company Period Transactions Value $ Form Type Role Filing Time
NAGE Niagen Bioscience, Inc. 19 Feb 2026 1 $0 4 Chief Financial Officer 24 Feb 2026, 16:46
NAGE Niagen Bioscience, Inc. 14 Nov 2025 2 +$45,616 4 Chief Financial Officer 17 Nov 2025, 08:23
NAGE ChromaDex Corp. 12 Feb 2025 1 $0 4 Chief Financial Officer 14 Feb 2025, 18:18
NAGE ChromaDex Corp. 22 Nov 2024 1 +$21,397 4 Chief Financial Officer 25 Nov 2024, 07:28
NAGE ChromaDex Corp. 21 Oct 2024 1 $0 4 Chief Financial Officer 23 Oct 2024, 17:04
NAGE ChromaDex Corp. 21 Oct 2024 0 $0 3 Chief Financial Officer 23 Oct 2024, 17:03
ATNF 180 Life Sciences Corp. 04 Sep 2023 1 $0 4 CFO 06 Sep 2023, 18:30
ATNF 180 Life Sciences Corp. 18 May 2023 1 +$5,214 4 CFO 19 May 2023, 08:30
ATNF 180 Life Sciences Corp. 10 Dec 2021 1 +$14,706 4 Interim CFO 13 Dec 2021, 07:31